These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 24377611)

  • 1. Prognostic and predictive value of PDL1 expression in breast cancer.
    Sabatier R; Finetti P; Mamessier E; Adelaide J; Chaffanet M; Ali HR; Viens P; Caldas C; Birnbaum D; Bertucci F
    Oncotarget; 2015 Mar; 6(7):5449-64. PubMed ID: 25669979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midkine in plasma as a novel breast cancer marker.
    Ibusuki M; Fujimori H; Yamamoto Y; Ota K; Ueda M; Shinriki S; Taketomi M; Sakuma S; Shinohara M; Iwase H; Ando Y
    Cancer Sci; 2009 Sep; 100(9):1735-9. PubMed ID: 19538527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades.
    Dyachenko L; Havrysh K; Lytovchenko A; Dosenko I; Antoniuk S; Filonenko V; Kiyamova R
    Dis Markers; 2016; 2016():5128720. PubMed ID: 27847402
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical analysis of the novel breast cancer serum assay BT1.
    Whitehurst MM; Aldenderfer PH; Yanovich S; Strelkauskas AJ
    Anticancer Res; 1999; 19(2A):1331-5. PubMed ID: 10368695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profile of interleukin-6, 4-hydroxy-2-nonenal, and hypoxia-inducible factor 1-α in women with breast cancer and their association with clinicopathological parameters.
    Yahia S; Tahari Z; Medjdoub A; Tahari FZ; Bessaih N; Messatfa M; Deblaoui F; Raiah M; Ouldcadi H; Seddiki S; Sahraoui T
    Contemp Oncol (Pozn); 2023; 27(1):14-21. PubMed ID: 37266334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast tumor tissue inflammation but not lobular involution is associated with survival among breast cancer patients in the Multiethnic Cohort.
    Maskarinec G; Ju D; Shvetsov YB; Horio D; Chan O; Loo LWM; Hernandez BY
    Cancer Epidemiol; 2020 Apr; 65():101685. PubMed ID: 32058311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches.
    Cruceriu D; Baldasici O; Balacescu O; Berindan-Neagoe I
    Cell Oncol (Dordr); 2020 Feb; 43(1):1-18. PubMed ID: 31900901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of inflammation with frailty in patients with breast cancer aged 50 and over receiving chemotherapy.
    Gilmore N; Kadambi S; Lei L; Loh KP; Mohamed M; Magnuson A; Cole S; Esparaz BT; Giguere JK; Mohile S; Janelsins M
    J Geriatr Oncol; 2020 Apr; 11(3):423-430. PubMed ID: 30992181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic analysis of breast cancer incidence, prevalence, and mortality in India: Protocol for a systematic review and meta-analyses.
    Madhav MR; Nayagam SG; Biyani K; Pandey V; Kamal DG; Sabarimurugan S; Ramesh N; Gothandam KM; Jayaraj R
    Medicine (Baltimore); 2018 Dec; 97(52):e13680. PubMed ID: 30593138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammographic density and breast tissue expression of inflammatory markers, growth factors, and vimentin.
    Maskarinec G; Ju D; Fong J; Horio D; Chan O; Loo LWM; Hernandez BY
    BMC Cancer; 2018 Nov; 18(1):1191. PubMed ID: 30497427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Benefits of Acupuncture for the Reduction of Hormone Therapy-Related Side Effects in Breast Cancer Patients: A Systematic Review.
    Pan Y; Yang K; Shi X; Liang H; Shen X; Wang R; Ma L; Cui Q; Yu R; Dong Y
    Integr Cancer Ther; 2018 Sep; 17(3):602-618. PubMed ID: 30117343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical and clinical aspects of TNF-α and its receptors TNFR1 and TNFR2 in breast cancer.
    Martínez-Reza I; Díaz L; García-Becerra R
    J Biomed Sci; 2017 Dec; 24(1):90. PubMed ID: 29202842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical Role of Myeloid-Derived Suppressor Cells in Tumor-Induced Liver Immune Suppression through Inhibition of NKT Cell Function.
    Zhang H; Li Z; Wang L; Tian G; Tian J; Yang Z; Cao G; Zhou H; Zhao L; Wu Z; Yin Z
    Front Immunol; 2017; 8():129. PubMed ID: 28243237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
    Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tai chi chuan exercise for patients with breast cancer: a systematic review and meta-analysis.
    Pan Y; Yang K; Shi X; Liang H; Zhang F; Lv Q
    Evid Based Complement Alternat Med; 2015; 2015():535237. PubMed ID: 25793000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overall survival and clinicopathological characteristics of patients with breast cancer in relation to the expression pattern of HER-2, IL-6, TNF-α and TGF-β1.
    Tripsianis G; Papadopoulou E; Romanidis K; Katotomichelakis M; Anagnostopoulos K; Kontomanolis E; Botaitis S; Tentes I; Kortsaris A
    Asian Pac J Cancer Prev; 2013; 14(11):6813-20. PubMed ID: 24377611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of IL-6 and TNF-α: prognostic significance on breast cancer outcome.
    Tripsianis G; Papadopoulou E; Anagnostopoulos K; Botaitis S; Katotomichelakis M; Romanidis K; Kontomanolis E; Tentes I; Kortsaris A
    Neoplasma; 2014; 61(2):205-12. PubMed ID: 24299316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
    Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
    Yie SM; Luo B; Ye NY; Xie K; Ye SR
    Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.